Affordable Access

Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery

Dove Press
Publication Date
  • Clinical Ophthalmology
  • Medicine


Philip TH Lam, Alvin L Young, Lulu L Cheng, Patrick MK Tam, Vincent YW LeeDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, ChinaObjective: To compare the safety profiles of intracameral cephalosporins in cataract surgery.Patients and methods: In this controlled trial, 129 patients were randomized to one of four groups to receive 1 mg of one of three cephalosporins – cefazolin, cefuroxime, or ceftazidime, or normal saline – given intracamerally during cataract surgery. Central endothelial cell density (ECD) and retinal center point thickness (CPT) were determined by specular microscopy and ocular coherence tomography, respectively, before and at 3 months after surgery.Results: There were no statistical significant differences in the changes of ECD and CPT between eyes receiving intracameral cephalosporin and control.Conclusion: The use of intracameral cefazolin, cefuroxime, or ceftazidime (1 mg in 0.1-mL solution) at the time of cataract surgery had no significant effect on ECD and CPT postoperatively.Keywords: intracameral cephalosporin, endophthalmitis, phacoemulsification

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times